Glenmark to launch Ropivacaine Hydrochloride Injection USP in the US
Marc Kikuchi, President & Business Head, North America, highlights the new addition to Glenmark’s injectable portfolio and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Strides Pharma to market WHO-prequalified generic DMPA-SC in Africa
The company highlights expanded access to affordable contraceptive options through global collaboration
Syngene International adds GMP bioconjugation suite at Bengaluru facility to expand ADC capabilities
The new OEB-5 rated suite will enable end-to-end antibody-drug conjugate (ADC) services from discovery to GMP manufacturing at a…
Merck to pour over $70 billion into US expansion
The company outlines a series of large-scale projects across Virginia, Delaware, North Carolina, and New Jersey as part of its…
Waters Corporation launches Xevo Charge Detection Mass Spectrometer for large biomolecule analysis
The new Xevo CDMS system enables measurement of large biomolecules to support research and development in gene and protein-based…
Eli Lilly reports positive Phase 3 results for orforglipron in type 2 diabetes trials
Eli Lilly highlights findings from two late-stage trials demonstrating orforglipron’s effectiveness in improving blood sugar…
Alembic Pharmaceuticals secures USFDA approval for Triamcinolone Acetonide Injectable Suspension
Alembic Pharmaceuticals highlights expansion of its US portfolio with new injectable therapy approval
Astellas-Pfizer’s combination therapy halves risk of death in bladder cancer patients
The therapy reduces tumor recurrence and death risk in bladder cancer patients
Biocon Biologics expands partnership with Civica to launch Insulin Glargine in the US
Biocon Biologics and Civica collaboration aims to increase access to affordable insulin in the United States
EU policy reforms and pharma investments highlight shifting industry priorities: GlobalData
GlobalData highlights how EU policy reforms and major pharma investments are reshaping industry strategies and priorities